| Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results JA Haller, F Bandello, R Belfort Jr, MS Blumenkranz, M Gillies, J Heier, ... Ophthalmology 118 (12), 2453-2460, 2011 | 890 | 2011 |
| A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study): 12-month data: report 2 M Michaelides, A Kaines, RD Hamilton, S Fraser-Bell, R Rajendram, ... Ophthalmology 117 (6), 1078-1086. e2, 2010 | 721 | 2010 |
| A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3 R Rajendram, S Fraser-Bell, A Kaines, M Michaelides, RD Hamilton, ... Archives of ophthalmology 130 (8), 972-979, 2012 | 543 | 2012 |
| Central serous chorioretinopathy: a review of epidemiology and pathophysiology G Liew, G Quin, M Gillies, S Fraser‐Bell Clinical & experimental ophthalmology 41 (2), 201-214, 2013 | 461 | 2013 |
| Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study S Fraser-Bell, M Guzowski, E Rochtchina, JJ Wang, P Mitchell Ophthalmology 110 (1), 34-40, 2003 | 393 | 2003 |
| A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study MC Gillies, LL Lim, A Campain, GJ Quin, W Salem, J Li, S Goodwin, ... Ophthalmology 121 (12), 2473-2481, 2014 | 367 | 2014 |
| Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double … JS Heier, AM Khanani, CQ Ruiz, K Basu, PJ Ferrone, C Brittain, ... The Lancet 399 (10326), 729-740, 2022 | 327 | 2022 |
| Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two … CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ... The Lancet 399 (10326), 741-755, 2022 | 278 | 2022 |
| Refractive error, ocular biometry, and lens opalescence in an adult population: the Los Angeles Latino Eye Study C Shufelt, S Fraser-Bell, M Ying-Lai, M Torres, R Varma Investigative ophthalmology & visual science 46 (12), 4450-4460, 2005 | 278 | 2005 |
| OCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implant D Zur, M Iglicki, C Busch, A Invernizzi, M Mariussi, A Loewenstein, ... Ophthalmology 125 (2), 267-275, 2018 | 245 | 2018 |
| Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study R Varma, S Fraser-Bell, S Tan, R Klein, SP Azen, ... Ophthalmology 111 (7), 1288-1297, 2004 | 211 | 2004 |
| Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study S Fraser-Bell, J Wu, R Klein, SP Azen, R Varma, ... American journal of ophthalmology 141 (1), 79-87, 2006 | 195 | 2006 |
| Hypertensive eye disease: a review S Fraser‐Bell, R Symes, A Vaze Clinical & experimental ophthalmology 45 (1), 45-53, 2017 | 177 | 2017 |
| Dexamethasone implant for diabetic macular edema in naive compared with refractory eyes: the international retina group real-life 24-month multicenter study. The IRGREL-DEX study M Iglicki, C Busch, D Zur, M Okada, M Mariussi, JK Chhablani, Z Cebeci, ... Retina 39 (1), 44-51, 2019 | 159 | 2019 |
| Prevalence and associations of epiretinal membranes in latinos: the Los Angeles Latino Eye Study S Fraser-Bell, M Ying-Lai, R Klein, R Varma Investigative ophthalmology & visual science 45 (6), 1732-1736, 2004 | 152 | 2004 |
| Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study S Fraser-Bell, J Wu, R Klein, SP Azen, C Hooper, AWP Foong, R Varma, ... American journal of ophthalmology 145 (2), 308-316, 2008 | 120 | 2008 |
| Diagnosis and interventions for central serous chorioretinopathy: review and update G Quin, G Liew, IV Ho, M Gillies, S Fraser‐Bell Clinical & experimental ophthalmology 41 (2), 187-200, 2013 | 119 | 2013 |
| Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema C Busch, D Zur, S Fraser-Bell, I Laíns, AR Santos, M Lupidi, C Cagini, ... Acta diabetologica 55, 789-796, 2018 | 116 | 2018 |
| Incidence and outcomes of infectious and noninfectious endophthalmitis after intravitreal injections for age-related macular degeneration V Daien, V Nguyen, RW Essex, N Morlet, D Barthelmes, MC Gillies, ... Ophthalmology 125 (1), 66-74, 2018 | 102 | 2018 |
| Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the … M Michaelides, S Fraser-Bell, R Hamilton, A Kaines, C Egan, C Bunce, ... Retina 30 (5), 781-786, 2010 | 97 | 2010 |
